SSSteven Shamah

Steven Shamah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Steven Shamah has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Noam Peleg

    Rabin Medical Center, Petah Tikva, Israel

    2 shared publications
  • Boris Sapoznikov

    The Division of Gastroenterology, Rabin Medical Center, Petah-Tikva 49100, Israel

    1 shared publication
  • C. G. Chapman

    Center for Endoscopic Research and Therapeutics (CERT), University of Chicago Medicine, 5700 S. Maryland Avenue, MC 8043, Chicago, IL, 60637, USA

    1 shared publication
  • C. Liao

    Center for Endoscopic Research and Therapeutics (CERT), University of Chicago Medicine, 5700 S. Maryland Avenue, MC 8043, Chicago, IL, 60637, USA

    1 shared publication
  • H. Haider

    Center for Endoscopic Research and Therapeutics (CERT), University of Chicago Medicine, 5700 S. Maryland Avenue, MC 8043, Chicago, IL, 60637, USA

    1 shared publication
  • I. Waxman

    Center for Endoscopic Research and Therapeutics (CERT), University of Chicago Medicine, 5700 S. Maryland Avenue, MC 8043, Chicago, IL, 60637, USA

    1 shared publication

Latest Publications

  • Open Access

    Pre-Procedural Predictors of Successful Endoscopic Sleeve Gastroplasty: A Retrospective Study

    by Lior Charach, Noam Peleg, Ran Abuhasira, Steven Shamah

    Objective: Obesity is a major risk factor for the morbidity and mortality of cardiovascular disease and predicts the development of hypertension, diabetes mellitus and other various diseases. Methods: A retrospective study evaluated predictors for higher total body weight loss following endoscopic sleeve gastroplasty (ESG). Adults (>18 years old) with BMI > 30 kg/m2 who underwent ESG from January 2019 to July 2022 were included. Patients under the age of 18 were excluded from the study. Results: This retrospective cohort included 76 patients, of whom 62 women (81.6%) and 14 were men (18.4%) with a mean age of 46.3 ± 10.4. The mean BMI baseline was 36.6 ± 4.21. Out of the included patients, 10% were lost to follow-up at 1 month, 33% at 3 months, 50% after 6 months, and only 30% met 12 months follow-up. During the follow-up period, no mortality was documented. Three major adverse events (3.9%) were documented (one mediastinal abscess, one lower gastrointestinal bleeding and one pulmonary embolism), all of them in female patients. Among the demographic clinical and laboratory data examined, smoking (N = 6, p < 0.001) was associated with successful ESG, which was determined as total body weight loss (TBWL) above 15%. The rest of the variables examined were not shown to be statistically significant to sleeve success. Overall, 65 of the 76 patients which were studied in this research had more than 5% TBWL, 42 patients had more than 10% TBWL, 21 patients had more than 15% TBWL and 7 patients lost more than 20% of their weight during 1 year of follow-up. Maximal TBWL was achieved 3 months following the procedure. During the first month following ESG, the average weight lost was 8.6% (N = 69); at 3 months, it was 12.3% (N = 48); at 6 months, it was 11.3% (N = 33); and at 12 months, it was 9.8% (N = 13). Smoking was associated with higher weight loss. Conclusions: The current study showed a positive correlation between ESG weight loss above 15% and smoking. Older patients (>50) gained weight earlier, within 3 months, and by 1 year of follow-up almost returned back to their original weight. Females sustained weight loss over 1 year of follow-up compared to males. Patients with lower BMI continued losing weight during the follow-up period (12 months). This study tries to summarize pre-procedural prediction of ESG success.

  • Open Access

    Seattle Protocol Is More Effective in Detection of Dysplasia Compared to Technology-Assisted Targeted Biopsies in Patients with Barrett’s Esophagus

    by Noam Peleg, Jacob E. Ollech, Steven Shamah, Boris Sapoznikov

    Background and aims: With the development of narrow-band imaging (NBI) in the endoscopic evaluation of patients with Barrett’s esophagus (BE), the role of random biopsies according to the Seattle protocol (SP) has been questioned. We aim to compare the utility of advanced imaging to SP in patients with BE. Methods: A prospective cohort of patients with proven BE was retrospectively analyzed. All biopsies were reviewed by an expert GI pathologist. Advanced imaging was tandemly used with SP in each endoscopic procedure. Results: A total of 155 out of 340 patients (45.5%) with BE were diagnosed with dysplasia during a median follow-up of 4.7 years (IQR 3.4–6.1 years) and were part of the statistical analysis. A total of 82 patients had a diagnosis of dysplasia at presentation, whereas 84 patients developed dysplasia during follow up. A total of 67 out of 82 patients with dysplasia at presentation (81.7%), and 65 out of 84 patients that were diagnosed with dysplasia during follow-up (77.4%) were diagnosed using SP. In addition, whereas all the events of EAC were diagnosed using targeted biopsies, 57.1% of the events of HGD and 86.3% of LGD were diagnosed using SP. Conclusion: Our findings demonstrate the significance of SP in the detection of low- and high-grade dysplasia in patients with BE. SP should remain the mainstay of endoscopic surveillance in this population.


  • Partially Covered Versus Uncovered Self-Expandable Metal Stents: Coating Nor Diameter Affect Clinical Outcomes

    by S. P. Shamah, C. G. Chapman, H. Haider, C. Liao, I. Waxman, U. D. Siddiqui

    Jaundice is a common initial presentation of malignant biliary stricture. In patients with life expectancies that are greater than 3 months, self-expanding metal stents (SEMS) offer a larger diameter stent with longer patency and fewer complications compared to plastic stents. There have been conflicting results in the published literature as to efficacy and safety between the various SEMS types and diameters. We compared stent coating (PCSEMS vs USEMS) and diameter on clinical outcomes regarding management of malignant biliary obstruction.


  • Open Access

    Rhabdomyolysis after fish consumption: Haff's disease

    by V. Paul, S. Shamah, O. Garankina, L. Wolf, Y. Shia Lin

    A 48-year-old male with no significant past medical history came to the emergency department (ED) because of sudden onset of diffuse myalgia especially in the legs, chest and back. It was associated with mild diaphoresis. Symptoms started acutely as he was driving back home from his work as a cab driver. He denied fever, new medications, recreational drug use, recent illness, significant physical exertion and trauma. Vital signs on admission were: temperature, 98.2 F; pulse, 90/min; blood pressure, 148/88 mm Hg; and SaO2, 98% on room air. Physical examination was significant for tenderness in the thighs and shoulder area, without weakness. The patient was passing dark brown coloured urine in the ED. Electrocardiogram showed normal sinus rhythm, without irregularities. His laboratory testing showed normal haemoglobin and white cell count. Urinalysis was positive with 4+ haemoglobin, but minimal grouped red blood cells. Urine toxicology screen was negative. Creatinine Phosphokinase (CPK) was 16192 IU/l (normal 41–85) on admission and peaked at >160,000, 40 h later. Serum myoglobin was elevated as well > 4000 ng/ml, on admission. (Such high values are rarely seen, except in cases of crush injuries.) Diagnosis of rhabdomyolysis was made, but the etiology was unknown. He was started on intravenous normal saline at a rate of 200 cc/h, with strict monitoring of urine output. His urine output was maintained around 2–3 ml/kg/h. Labs done 4 h later revealed hyperkalemia and elevation of serum creatinine, consistent with acute kidney injury due to tubular toxicity (ATN) of myoglobin. His myalgias lasted for about 10–12 h, and then resolved. CPK and myoglobin started to improve on day 4. The acute kidney injury was likely ATN, due to myoglobulinuria, and creatinine increased rapidly to 3.0 mg/dl within 48 h, peaked at 3.6 mg/dl on day 5, and then started improving. Rheumatologic work up including Anti-nuclear antibody was negative. His mother had been hospitalized the month prior, for weakness secondary to rhabdomyolysis, which led to renal failure. Her hospital course was complicated by intracranial haemorrhage and expiration. She had eaten buffalo fish before she was admitted. Our patient, had taken out soup fish from the freezer one month later which was made from the same fish, and ingested it. Diagnosis of Haff disease was established on basis of compatible history, laboratory findings, and in consultation with Center for Disease Control. Patient was discharged on day 6, asymptomatic, and improving renal function.